Improving antibody-mediated protection against HSV infection by eliminating interactions with the viral Fc receptor gE/gI https://t.co/m5KJyH2zpw #biorxiv_immuno
We just got word that an anonymous donor has agreed to match ALL DONATIONS THIS WEEK up to $10,000!!! Thank you so much to our generous donor and remember to donate to our Strike Fund ❤️:
https://t.co/nR3iB8MTMG
It is outrageous that while Dartmouth has an endowment of $7.9 billion, their graduate workers are struggling to get by. I stand in solidarity with 800 workers of @GOLDartmouth striking for a living wage and decent benefits.
https://t.co/sVRXuC305u
Online now: Effector functions are required for broad and potent protection of neonatal mice with antibodies targeting HSV glycoprotein D https://t.co/uTfVJhYXxC
Study by Professor Margie Ackerman and Ackerman Lab/@GeiselMed students @mattslein and Iara Backes offers new insights on how antibodies combat HSV infections. This could lead to new treatments for neonatal herpes—one of the deadliest neonatal infections. https://t.co/FTYF6hmMDf
My first first-author paper of grad school is live on @CellRepMed https://t.co/LZ0HKXwzfc It was a labor of love resulting in a very interesting story on how antibodies protect neonatal mice from HSV infections
Antibody effector functions are required for broad and potent protection of neonates from herpes simplex virus infection https://t.co/VtieQej4bw #biorxiv_immuno
Our first bargaining session is today at 1PM EST! We are so excited to finally meet our employer at the table! Check your email for details on open bargaining.